Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Biosimilars Provision In Pacific Trade Deal Adds Fuel To Generic Fight

This article was originally published in The Pink Sheet Daily

Executive Summary

As negotiations over Trans-Pacific Partnership Agreement near completion, generic drug advocates make all-out push to eliminate IP provisions, particularly one they say would create patent linkage for biologics.

Advertisement

Related Content

India-Style Patent Laws Targeted In Trans-Pacific Trade Negotiations

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register